Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/11 → 4/30/12 |
Funding
- Biocryst Pharmaceuticals, Inc.: $10,660.00
Evaluation of the antiviral activity of compound BCX-4430 against Ebola and Marburg viruses in vitro
- Geisbert, Thomas (PI)
Project: Research project